News & Insights
Sort By
Insights 3 Results
Insights
|May 4, 2023
The FutureWork Playbook Podcast Season 4, Episode 2: “ESG Now! Preparing for Exit at Inception”
The FutureWork Playbook episode 2, “ESG Now! Preparing for Exit at Inception,” hosted by partner and chair of employment & labor practice Natalie Pierce, is out now.
Insights
|August 3, 2021
Since the start of the Biden administration, the U.S. Securities and Exchange Commission (SEC) has signaled that climate and broader environmental, social and governance (ESG) disclosure will be an area of heightened focus, subject to more proactive and aggressive regulatory oversight and enforcement.
Insights
|May 21, 2021
Once considered an unorthodox path to going public, direct listings are gaining traction as an alternative to the traditional IPO. On Wednesday, the Securities and Exchange Commission (SEC) approved a rule change, with immediate effect, that will permit companies to raise capital in a direct listing on the Nasdaq Global Select Market.
Events 12 Results
Events
|March 17, 2026
Post-IPO: Engaging Shareholders with Confidence and Credibility
This webinar equips GCs and CFOs of public companies with strategies to navigate shareholder communications, from annual meetings to investor engagement, with insights from Gunderson Dettmer’s Alexa Belonick and Brett Pletcher
Events
|December 11, 2025
Katten and Gunderson Dettmer discusses the SEC’s recent policy statement on mandatory securities arbitration and whether it represents a meaningful shift for companies and their investors
Events
|April 3, 2025
Gunderson Dettmer and Katten’s seasoned attorneys lead an insightful webinar exploring the legal risks and regulatory trends surrounding AI-focused litigation
Client News 15 Results
Client News
|March 11, 2026
Hims & Hers Announces Agreement to Acquire Eucalyptus
Hims & Hers, the leading health and wellness platform, announces its agreement to acquire Australian-based digital health leader, Eucalyptus, for up to $1.15 billion.
Client News
|February 25, 2026
Gunderson Dettmer Advises Vir Biotechnology on Underwritten Public Offering
Vir Biotechnology announces its underwritten public offering of 20,294,117 shares of common stock at $8.50 per share, including the exercise in full of the underwriters’ option to purchase additional shares.
Client News
|December 19, 2025
Gunderson Dettmer Represents Client Andersen Group in its $202.4 million IPO
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP represented Andersen Group Inc. (NYSE: ANDG), a leading provider of independent tax, valuation and financial advisory services to individuals and family offices, businesses and funds in the United States, in its initial public offering of 12,650,000 shares of its Class A common stock, at a public offering price of $16 per share.
Firm News 2 Results
Firm News
|February 7, 2022
Gunderson Dettmer Grows Headcount 30% in 'Banner Year' Driven by Tech and Life Sciences Boom
This article was first released by Law.com on January 26, 2022.
Tremendous demand from tech and life sciences clients fueled a historic year of growth in 2021 for Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, according to firm leadership.
Firm News
|March 22, 2021
Gunderson Dettmer is pleased to announce that Alexa Belonick has joined the firm as a Partner in its San Francisco office and a member of its Public Offerings/Public Companies practice.
